The debate on the need for vaccinate the very youngi (in particular the 12-16 year-olds) holds court not only in Italy but in several Countries of Europe and the World. So far, among the vaccines on the market, only Pfizer has been given the ok for administration in the children and teenagers between 12 and 16. In this context, Germany has decided to advise against the administration of the vaccine in this age group for healthy subjects, reserving it for those with pathologies.
The use of Comirnaty, the anti-Covid vaccine of Pfizer BioNTech, “in children and adolescents aged 12-17 years with no previous illnesses it is currently not generally recommended”. And the widespread recommendation in Germany by the Standing Committee on Vaccination (Stiko) at the Robert Koch Institute. Experts advise that children and adolescents come vset up against the coronavirus Sars-CoV-2 only if they suffer from certain diseases.
The risk-benefit ratio (it is useful to remember that the development of severe forms of Covid-19 in children and young people is rare) therefore leads German scientists to advise against the vaccine for the youngest.
© All rights reserved